They're already there—you just need to learn how to get them to behave the way you want.
Since Aristotle, the salamander's gift of regrowth has seemed beyond the reach of mammals — a biological boundary written into our nature. Researchers at Texas A&M University have now shown that the boundary may be a choice, not a limit: mammalian cells already carry the machinery for regeneration, but default to scarring instead. By redirecting that cellular decision with targeted growth factors, the team coaxed mice to regrow bone, tendons, and ligaments after amputation — not perfectly, but undeniably. The question biology has carried for centuries has quietly changed its shape: no longer whether mammals can regenerate, but how to teach them to do it well.
- A central assumption of regenerative medicine — that mammals simply lack what salamanders possess — has been overturned by a single study in mice.
- The real tension is a fork in the road: injured mammalian cells race toward scarring by default, locking out the regenerative pathway before it can begin.
- Texas A&M researchers intervened with two naturally occurring growth factors, first nudging cells away from fibrosis and then instructing them to build new tissue — bone, tendons, ligaments — where only a wound had been.
- The regrown structures were functional but imperfect, a result that is simultaneously humbling and historic: proof of concept without proof of completion.
- The findings suggest future therapies need not import stem cells from outside the body — the regenerative cells are already resident, dormant, waiting for the right signal.
- Human applications remain years away, but the field's horizon has shifted: the goal is no longer to discover whether mammalian regeneration is possible, but to refine how precisely it can be directed.
For centuries, the gap between a salamander's effortless regrowth and a human's permanent scar has seemed absolute — a biological law rather than a biological habit. A study published in Nature Communications by researchers at Texas A&M University now suggests the difference is less about what mammals lack and more about what they have learned to do instead.
When injury strikes, mammalian cells called fibroblasts arrive at the wound and make a choice: scar. The process, called fibrosis, is fast and effective at sealing damage, but it forecloses regeneration. In salamanders, those same cells take a different path, forming a mass of regenerative tissue called a blastema — a cellular foundation from which new structures grow. The Texas A&M team asked whether mammalian cells could be redirected down that same road.
Their answer was a two-stage treatment using naturally occurring growth factors. First, fibroblast growth factor 2 encouraged wound cells to form a blastema-like structure rather than continuing toward scar. Then bone morphogenetic protein 2 instructed those cells to begin building new tissue. Treated mice regrew bone, tendons, ligaments, and joint structures — not as perfect replicas of what was lost, but as functional, real anatomy where none had been expected.
Lead researcher Professor Ken Muneoka was precise about what the result means: the structures are there, just not in perfect form. That qualification matters — but so does the achievement it qualifies. Perhaps more striking still, the study challenges the assumption that regeneration requires stem cells introduced from outside the body. The cells needed are already present in mammalian tissue, dormant rather than absent, waiting for instructions they have never before received.
The work is early, demonstrated only in mice, and human applications remain years away. But as co-author Larry Suva observed, showing that regeneration can be activated opens entirely new questions. The field's ambition need not stop at regrowing missing limbs — even reducing fibrosis and improving ordinary wound healing would transform medicine. The question biology has carried since Aristotle has not been answered so much as reframed: mammals can regenerate. The work now is learning to do it well.
For centuries, the gap between what salamanders can do and what humans can do has seemed absolute. A salamander loses a limb and grows it back, perfect and whole. A human loses a limb and the body seals the wound with scar tissue, a permanent closure. That difference—why some animals regenerate and others do not—is a question that has haunted biology since Aristotle asked it. Now researchers at Texas A&M University have found that the answer may not be about what mammals lack, but about what they're choosing to do instead.
In a study published in Nature Communications, the team demonstrated that mice could regrow complex tissues—bone, tendons, ligaments, joint structures—after amputation, if the right signals were sent at the right time. The regeneration was not perfect. The regrown limbs were functional but misshapen, lacking the precision of the original anatomy. Yet the fact of regrowth itself upended a central assumption in regenerative medicine: that mammals simply cannot do what salamanders do.
The mechanism turns out to be a fork in the road. When a mammal is injured, specialized cells called fibroblasts arrive at the wound site and begin repair work. In humans and most mammals, these cells follow a well-worn path: they form scar tissue, a process called fibrosis. Scarring is efficient. It closes the wound quickly and prevents infection. But it also locks the door on regeneration. In salamanders and other animals capable of regrowing limbs, the cells take a different route. Instead of scarring, they form a mass of regenerative cells called a blastema—a kind of cellular foundation on which new tissue can be built.
The Texas A&M team asked a simple question: could mammalian cells be redirected down the salamander's path? They developed a two-stage treatment using naturally occurring growth factors. First, they applied fibroblast growth factor 2 (FGF2) to the wound after it had healed, encouraging cells to form a blastema-like structure instead of continuing toward scarring. Then they applied a second signal, bone morphogenetic protein 2 (BMP2), which instructed those cells to begin constructing new tissues. The treated mice regrew multiple structures that would normally be lost to amputation.
Professor Ken Muneoka, who led the study, described the result with careful precision: "We regenerated what you would expect to see at that level of injury. The structures are there—just not in a perfect form." That qualification matters. The regenerated anatomy was not an exact replica of what was lost. But it was there. It was functional. It was real.
The findings also challenge a foundational belief in regenerative medicine: that stem cells must be introduced from outside the body to trigger repair. The Texas A&M work suggests otherwise. The cells needed for regeneration are already present in mammalian tissue. They are not absent. They are dormant, waiting for the right instructions. "You don't have to actually get stem cells and put them back in," Muneoka said. "They're already there—you just need to learn how to get them to behave the way you want."
The team also uncovered evidence that cells can be reprogrammed to build structures outside their usual developmental role, a process called positional re-specification that is central to how animals capable of limb regeneration actually work. This suggests that the cellular machinery for regeneration may be far more universal in mammals than previously thought—not missing, but switched off.
The work remains early. It has been demonstrated only in mice. The regenerated tissues are not perfect replicas of what was lost. But co-author Larry Suva captured the shift in thinking the study represents: "Once you show that regeneration can be activated, it opens the door to asking entirely new questions." Those questions could eventually lead to treatments for injuries that currently result in permanent scarring or loss of function. Rather than focusing solely on regrowing missing body parts, future therapies might help wounds heal more effectively, reducing fibrosis and improving tissue repair. The question is no longer whether mammals can regenerate. It is how to teach them to do it well.
Citações Notáveis
Why some animals can regenerate and others, particularly humans, can't is a big question that has been asked since Aristotle.— Professor Ken Muneoka, lead researcher
Once you show that regeneration can be activated, it opens the door to asking entirely new questions.— Larry Suva, co-author
A Conversa do Hearth Outra perspectiva sobre a história
So the mice actually regrew limbs? Fully functional limbs?
Not fully. The structures were there—bone, tendons, ligaments—but they weren't perfect replicas. Think of it as functional regeneration rather than cosmetic. The point is the regeneration happened at all.
But why does it matter if it's not perfect? If humans could regrow a limb even imperfectly, that would change everything.
Exactly. That's what makes this a threshold moment. For decades, the assumption was that mammals simply couldn't do this. Now we know the capacity is there. It's dormant, not absent. That changes what we're looking for.
How did they wake it up?
With growth factors—chemical signals that told the cells to build a regenerative foundation instead of scar tissue. It's like redirecting traffic at an intersection. The cells were always going to respond to injury; the researchers just showed them a different route.
And this works because the cells are already there?
Yes. That's the real revelation. Regenerative medicine has been chasing stem cell therapies, trying to import healing from outside. But the study suggests the cells you need are already in your body. You just have to convince them to behave differently.
How long until this works in humans?
That's the honest question no one can answer yet. Years, probably. Maybe decades. But the door is open now in a way it wasn't before.